Literature DB >> 28244398

An Ultracentral Lung Tumor.

David A Palma1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28244398     DOI： 10.1016/j.ijrobp.2016.09.038

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN： 0360-3016            Impact factor:   7.038


× No keyword cloud information.
  3 in total

1.  Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer.

Authors:  Mao-Bin Meng; Huan-Huan Wang; Nicholas G Zaorsky; Bing-Shen Sun; Lei Zhu; Yong-Chun Song; Feng-Tong Li; Yang Dong; Jing-Sheng Wang; Hua-Ming Chen; Xu-Yao Yu; Zhi-Yong Yuan
Journal:  Cancer Sci       Date:  2019-09-09       Impact factor: 6.716

Review 2.  Stereotactic body radiotherapy (SBRT) for central and ultracentral node-negative lung tumors.

Authors:  Dawn Owen; Terence T Sio
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

Review 3.  Single-fraction stereotactic ablative body radiation therapy for primary and metastasic lung tumor: A new paradigm?

Authors:  Castalia Fernández; Arturo Navarro-Martin; Andrea Bobo; Joaquín Cabrera-Rodriguez; Patricia Calvo; Rodolfo Chicas-Sett; Javier Luna; Nuria Rodríguez de Dios; Felipe Couñago
Journal:  World J Clin Oncol       Date:  2022-02-24
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.